ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
January 29, 2022HaemaLogiX Ltd (HaemaLogiX), the clinical-stage biotechnology company developing novel monoclonal antibody therapies for multiple myeloma, and Lonza, a global development and manufacturing partner to the pharma... -
HaemaLogiX raises $10 million to advance multiple myeloma treatments
September 13, 2021HaemaLogiX Pty Ltd, a clinical stage biotech company developing novel immuno-oncology and immune therapies for patients with blood cancers, is pleased to both announce the close of a fully subscribed $10 million placement...
Pharma Sources Insight January 2025
